AlphAIAlphAI — Financial news for AI agents
marketscreener.comOCT 81 min read$CME

Rothschild & Co Redburn Adjusts Price Target on CME to $330 From $317

Rothschild & Co Redburn raised its price target for CME Group to $330 from $317. CME's stock is currently trading at $270.27, with a 5-day change of +0.03% and a year-to-date change of +3.16%.

Original reporting
marketscreener.com
Published Oct 8, 2026, 12:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 12:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$CME
Bullish
medium confidence
Mentioned
$CME
Relevance
5/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$CMEBullishLow
01

Why it matters

Analyst upgrades can influence short‑term price action, though without fresh company data the effect may be modest.

02

Market read

A modest analyst target increase may generate limited buying interest in CME shares.

03

What to watch

No new earnings or guidance data accompany the target change.

Relevance 5/10Novelty 5/10Timing: pre‑market today

Background

The article reports a price‑target adjustment by Rothschild & Co Redburn for CME Group.

Company-level read

Ticker impact

$CMEBullishMedium confidence
Context

Rothschild & Co Redburn raised its price target on CME to $330 from $317.

Expected impact

potential upward pressure as the market prices in the higher target

Evidence & confidence

Target hikes are often interpreted as bullish, encouraging buying interest.

Market effects

Sector

May lift sentiment for the broader financial services sector.

Regional

Limited to U.S. equities market.

Global

Minimal global impact.

Counterpoint

What could challenge this read

Target raises can be premature if underlying fundamentals are unchanged.

Key entities

  • company
    CME Group

    U.S. listed exchange operator.

  • analyst_firm
    Rothschild & Co Redburn

    Equity research provider.

Read at source← All news

Related articles

OCT 11
$CMEMed

FanDuel Gets FCM License, Raising Questions Over CME Role in Predicts

FanDuel has received a futures commission merchant (FCM) license from the National Futures Association, allowing it more control over its U.S. prediction market business. The approval raises questions about its partnership with CME Group, which holds a 51% stake in FanDuel Predicts. CME's CEO previously stated that such a license could conflict with their agreement. FanDuel's new license does not permit it to operate its own exchange, but it may seek further approvals in the future.

bonus.com2 min
OCT 8
$CMEMed

Baseball may get its first stats-based trading contracts Oct. 12, pending regulatory review.

CME Group plans to launch baseball futures on October 12, 2026, pending regulatory approval. The contracts will track CME FutureSports Performance Indexes, based on official league data of 30 professional baseball teams. Standard contracts will be valued at 10x the indexes, while micro contracts will be 1/10 their value. Trading will begin with the 2026 Postseason and the four clubs in the League Championship Series.

stocktitan.net2 min
OCT 7
$FLUTHigh

FanDuel Lands FCM License, But CME Isn’t Involved

FanDuel, owned by Flutter Entertainment (FLUT), secured a futures commission merchant (FCM) license from the National Futures Association. This approval may alter FanDuel's relationship with CME Group (CME), the majority owner of FanDuel Predicts. FanDuel has been expanding its prediction market operations, including a partnership with Crypto.com. CME has expressed concerns about FanDuel's potential competitive threat.

casino.org2 min